Author: Editor

Spotlight Interview: Liz Cormier-May, CEO, Mammogen, Inc.

by Editor -

About Elizabeth Cormier-May Liz has been in the biotechnology industry for nearly 20 years, with a focus on early start-ups and company creation.  She started her career as a medicinal chemist for Novartis Institute for Biomedical Research, working in early discovery oncology.  She quickly realized that her ability to create meaningful

Industry News: Volume 1, Issue 23

by Editor -

COVID-19 Cases, Hospitalizations Drop as Poll Shows 20% of Adults Won’t Get Vaccinated By Cecelia Smith-Schoenwalder USNews.com—Nationwide coronavirus cases and hospitalization are down while a poll reports that the percentage of U.S. adults vaccinated or planning to get the shot is the highest it’s been this year. The U.S. is averaging over 110,000

Volume 1, Issue 22: Jeff Gary, CEO, OneShare Health Discusses Faith-Based Healthcare Program Offering Alternative to Costly Health Insurance Plans

by Editor -

Dear Colleagues, In this issue, we speak with Jeff Gary, CEO, OneShare Health, to discuss facilitating medical expenses and offering a unique alternative to costly health insurance plans through a faith-based ministry. This issue also brings you news on the call for pricing transparency and data accessibility, legal action from 24 states

Industry News: Volume 1, Issue 22

by Editor -

Stakeholder panel calls for stronger price transparency enforcement, data accessibility By Dave Muoio FierceHealthcare.com—Many U.S. hospitals have not been publishing their prices, as required by a new law. Now, a panel of researchers, purchasers and regulators is calling for new measures around increasing compliance and the usability of published pricing data.   To

Volume 1, Issue 21: Michael Werner, Partner; Sara Klock, Associate, Holland & Knight Discuss the Importance of Digital Service/Technology Providers Meeting FDA Regulation Requirements

by Editor -

Dear Colleagues, In this issue, we speak with Michael Werner, Partner and Sara Klock, Associate, Holland & Knight to discuss providing legal counsel and ensuring digital service/technology providers meet the appropriate regulatory requirements. This issue also brings you news on Recuro Health’s recent $15 Million Series A round funding, finding insights and

Spotlight Interview: Michael Werner, Partner; Sara Klock, Associate, Holland & Knight

by Editor -

About Michael Werner Michael Werner is a Washington, D.C., public policy and regulatory attorney and a co-leader of Holland & Knight's Healthcare & Life Sciences Team. Mr. Werner has almost three decades of healthcare law, lobbying, regulatory and reimbursement experience in Washington. He focuses on issues affecting FDA-regulated entities, including biotechnology

Industry News: Volume 1, Issue 21

by Editor -

Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth DALLAS--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes

Volume 1, Issue 20: Gitte Bach, President and CEO, New Frontier Group Discusses Bridging the Gap Between International Patients and Healthcare in the U.S.

by Editor -

Dear Colleagues, In this issue, we speak with Gitte Bach, President and CEO, New Frontier Group to discuss bridging the healthcare gap between international patients living or traveling abroad and receiving medical treatment in a different country. This issue also brings you news on the surge in international medical value travelers in